Evidence map›Paper›PMID 30804950›Full record

ArticleFrontiers in immunology2018

Residual Activatability of Circulating Tfh17 Predicts Humoral Response to Thymodependent Antigens in Patients on Therapeutic Immunosuppression.

Suzan Dahdal, Carole Saison, Martine Valette, Emmanuel Bachy, Nicolas Pallet, Bruno Lina, Alice Koenig, Guillaume Monneret, Thierry Defrance, Emmanuel Morelon and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. γδ T Cells' Role in Donor-Specific Antibody Generation: Insights From Transplant Recipients and Experimental Models.Transplant international : official journal of the European Society for Organ Transplantation · 2025
    Article
  6. Predictive factors of a viral neutralizing humoral response after a third dose of COVID-19 mRNA vaccine.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2022
    Article
  7. Article
  8. Review
  9. Review
  10. Characterization of circulating and cultured Tfh-like cells in sickle cell disease in relation to red blood cell alloimmunization status.Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis · 2020
    Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Suzan DahdalFrench National Institute of Health and Medical Research (Inserm) Unit 1111, Lyon, France.
Carole SaisonFrench National Institute of Health and Medical Research (Inserm) Unit 1111, Lyon, France.
Martine ValetteHospices Civils de Lyon, Croix-Rousse University Hospital, Infectious Agents Institute (IAI) Laboratory of Virology-National Reference Center for Respiratory Viruses (Including Influenza), Lyon, France.
Emmanuel BachyDepartment of Hematology, Hospices Civils de Lyon, Lyon Sud University Hospital, Pierre Bénite, France.
Nicolas PalletLaboratory of Biochemistry, Assistance Publique-Hôpitaux de Paris, Georges Pompidou Hospital, Paris, France.
Bruno LinaFrench National Institute of Health and Medical Research (Inserm) Unit 1111, Lyon, France.
Alice KoenigFrench National Institute of Health and Medical Research (Inserm) Unit 1111, Lyon, France.
Guillaume MonneretLaboratory of Immunology, Hospices Civils de Lyon, Edouard Herriot University Hospital, Lyon, France.
Thierry DefranceFrench National Institute of Health and Medical Research (Inserm) Unit 1111, Lyon, France.
Emmanuel MorelonFrench National Institute of Health and Medical Research (Inserm) Unit 1111, Lyon, France.
Olivier ThaunatFrench National Institute of Health and Medical Research (Inserm) Unit 1111, Lyon, France.
Inserm · FRHospices Civils de Lyon · FRHôpital de la Croix-Rousse · FRUniversité Claude Bernard Lyon 1 · FRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The generation of antibodies against protein antigens (such as donor-specific HLA molecules) requires that T follicular helper cells (Tfh) provide help to B cells. Immunosuppressive (IS) armamentarium prevents T cell activation, yet a significant proportion of renal transplant patients develop donor-specific antibodies (DSA), which suggests that IS drugs do not efficiently block T follicular helper cells. To test this hypothesis, the number of circulating Tfh, their polarization profile, and ability to up-regulate (i) the co-stimulatory molecules CD40L and ICOS, and (ii) the activation marker CD25, following

Indexed as

Immunity, HumoralImmunosuppression TherapyAdultAgedAntibody FormationAntigensFemaleHemagglutinin Glycoproteins, Influenza VirusHumansKidney TransplantationLymphocyte ActivationMaleMiddle AgedROC CurveTh17 CellsAntigensHemagglutinin Glycoproteins, Influenza Virusbiomarkersdonor-specific antibodiesimmunosuppressionTfhtransplantation

Identifiers

PMID30804950
PMCPMC6370621
OpenAlexW2912445847

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.